InvestSMART

USCOM Ltd (ASX:UCM)

ALERT: Price-sensitive ASX Announcement for UCM
Current share price for UCM : $0.012 -0.013 (-52%)+
Announcement
Release
29 Apr 2025 10:05AM
Price at Release
$0.025
Full Release
download
Summary
This document is the quarterly activities report and Appendix 4C cash flow report for USCOM Ltd for the quarter ending 31 March 2023. The report details operational progress, financial activity, and future outlook for the company. Key highlights include continued product development, regulatory progress, market expansion, and a focus on cash management. The company highlights ongoing sales of its products, advancements in regulatory submissions, and partnerships to increase its market presence globally. Financially, the report outlines receipts, payments, financing, and available cash at the end of the period. The company remains focused on maximizing sales opportunities, managing costs, and pursuing further regulatory approvals to drive future growth.
Key Points
  • Quarterly activities and cash flow report for quarter ending 31 March 2023.
  • Continued sales and market expansion of USCOM’s products, including Uscom 1A, BP+, and SpiroSonic.
  • Progress in regulatory submissions and approvals in key markets such as Europe, China, and the US.
  • Focus on research and development for next-generation medical devices.
  • Partnerships and distribution agreements to enhance global market coverage.
  • Financial summary includes customer receipts, operating expenditure, and end-of-quarter cash position.
  • No payments made to related parties outside of director fees and standard reimbursements.
  • Company remains focused on cash conservation and cost management.
  • Outlook includes ongoing product sales, regulatory progress, and pursuit of new market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.